Latest News & Features
Asia
Pharmaceutical company Teva has offered to buy fellow drug maker Mylan in a deal that could be worth $40 billion. 22 April 2015
Americas
The Supreme Court of Canada has dismissed an appeal by French pharmaceutical company Sanofi in its patent dispute with Canadian generic drug maker Apotex. 22 April 2015
Americas
Texas hedge fund manager Kyle Bass has sought another inter partes review, this time to challenge a patent covering Pharmacyclics’ cancer drug Imbruvica. 22 April 2015
Americas
Healthcare company Fresenius Kabi and India-based generic drug maker Claris Lifesciences have settled their patent dispute, ending pending litigation. 21 April 2015
Big Pharma
Law firm Taylor Wessing has promoted senior associates Matt Royle and Ed Vickers to partner and senior counsel, respectively. 21 April 2015
Americas
Mylan’s executive chairman Robert Coury has issued a statement confirming that his company and Teva will not merge. 20 April 2015
Americas
An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain. 20 April 2015
Big Pharma
Law firm Schiff Hardin has added a life sciences specialist as a partner in its intellectual property group. 17 April 2015
Americas
A product of decomposing leaf litter, exDNA could be a powerful tool for interacting with biological systems. If so, the IP associated with its applications may be an active area in the coming years, says non-practising barrister Charles Brabin. 16 April 2015
Americas
The US Court of Appeals for the Second Circuit has heard arguments surrounding whether Actavis should be allowed to discontinue its first Alzheimer’s drug Namenda to make way for an extended release version of the medicine. 16 April 2015